See also this year's filing and all EDGAR filings for this company.
PDF Report 0001012477_2017_Avadel_Pharmaceuticals_PLC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001012477, Avadel Pharmaceuticals PLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 181,186,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 41,328,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,320,000 |
| 3 | remainder_Assets | 19,648,000 |
| 4 | LiabilitiesCurrent | 62,421,000 |
| 5 | LiabilitiesNoncurrent | 5,822,000 |
| 6 | remainder_Liabilities | 135,170,000 |
| 7 | CostOfGoodsAndServicesSold | 13,248,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 44,179,000 |
| 9 | ResearchAndDevelopmentExpense | 34,611,000 |
| 10 | remainder_Expenses | 102,242,000 |
| 11 | remainder_Revenues | 150,246,000 |
| 12 | remainder_NetIncome | 2,758,000 |
| 13 | remainder_ComprehensiveNetIncome | -908,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 245,482,000 |
| 1 | Liabilities | 203,413,000 |
| 2 | Expenses | 194,280,000 |
| 3 | Revenues | 150,246,000 |
| 4 | StockholdersEquity | 42,069,000 |
| 5 | NetIncome | -41,276,000 |
| 6 | ComprehensiveNetIncome | -41,730,000 |
| 7 | BaseVar | 398,543,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.223 |
| 9 | EconomicCapitalRatio | 1.63 |
Edgar->Model Mapping
Feature Distribution
Change over Time
